Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
Billionaire Investor Takes New Stake In Thermo Fisher Scientific
01.05.2026 16:31
Hedge fund billionaire Daniel Loeb assumed a stake in the Life Sciences Tools & Services company Thermo Fisher Scientific Inc at Third Point LLC in the fourth quarter of FY25. As of Dec. 31, 2025, Loeb bought 50,000 shares in the company. Recent Key Events In February, Thermo Fisher Scientific’s Board approved a quarterly dividend of $0.47 per share, payable on April 15, 2026, to shareholders of record as of March 13, 2026. The new dividend represents a 10% increase from the prior $0.43 payout.
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds
29.04.2026 02:04
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Thermo Fisher selling microbiology business to Astorg for $1.08B
27.04.2026 14:38
The unit generated $645 million in revenue in 2025 and supplies products used in clinical, pharmaceutical, and food safety testing
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
27.04.2026 12:00
WALTHAM, Mass., April 27, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.
Astorg III, FCPR, managed by Astorg Asset Management S A.R.L. signed a definitive agreement to acquire Global Microbiology Business from Thermo Fisher Scientific Inc. for approximately $1.1 billion.
27.04.2026 10:20
Astorg III, FCPR, managed by Astorg Asset Management S A.R.L. signed a definitive agreement to acquire Global Microbiology Business from Thermo Fisher Scientific Inc. for approximately $1.1 billion...
Thermo Fisher to Sell Microbiology Business to Astorg for About $1.075 Billion
27.04.2026 08:53
By Colin Kellaher Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion. Thermo Fisher on Monday said...
Thermo Fisher to sell microbiology business to PE firm Astorg for over $1 billion
27.04.2026 08:34
Medical equipment maker Thermo Fisher Scientific said on Monday it would sell its microbiology business to private equity firm Astorg for about $1.08 billion. o Deal consists of cash...
Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion
27.04.2026 08:08
Thermo Fisher Scientificsaid on Monday it has agreed to sell its microbiology businessto a pan-European private equity firm Astorg for about $1.08billion, consisting of cash and a $50 million...
Thermo Fisher Scientific (TMO) Announces Fiscal Q1 2026 Results
27.04.2026 05:54
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best stem cell therapy stocks to buy. On April 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced financial results for fiscal Q1 2026. Revenue for the quarter rose 6% to $11.01 billion, compared to $10.36 billion in the same quarter last year. Organic revenue underwent a 1% growth. […]
Thermo Fisher Scientific Q1 Earnings Call Highlights
24.04.2026 10:08
Thermo Fisher Scientific (NYSE:TMO) reported what executives described as a “strong start” to 2026, posting first-quarter revenue growth and raising its full-year outlook after closing the acquisition of clinical trial technology provider Clario late in the quarter. First-quarter results and end-ma
Thermo Fisher Scientific Inc (TMO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
24.04.2026 07:06
Thermo Fisher Scientific Inc (TMO) reports a robust 6% revenue increase and raises full-year guidance, despite facing macroeconomic challenges.
Why Thermo Fisher (TMO) Stock Is Nosediving
24.04.2026 06:05
Shares of life sciences company Thermo Fisher (NYSE:TMO) fell 10.5% in the afternoon session after the company reported first-quarter results that revealed weak underlying growth in its core business.
Why 10x Genomics (TXG) Shares Are Trading Lower Today
24.04.2026 05:25
Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 5.4% in the afternoon session after a key industry peer, Thermo Fisher Scientific (TMO), reported mixed first-quarter results, sparking concerns about a potential slowdown in the life sciences sector.
Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation
22.04.2026 15:57
According to the latest analysis by Future Market Insights, the global Cloud Electronic Laboratory Notebook (ELN) Service market is entering a strong growth phase, driven by accelerating digital transformation in research environments, rising regulatory compliance requirements, and increasing demand for collaborative, cloud-based data management. Valued at USD 375.1 million in 2025, the market is projected to reach USD 1,156.0 million by 2035, expanding at a CAGR of 12.6%.
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings
22.04.2026 09:09
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings this Thursday before the bell. Here’s what to look for.
$10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031
22.04.2026 08:24
The global microbiology testing market is set to reach USD 10.09 billion by 2031, growing from USD 7.79 billion in 2026 at a CAGR of 5.3%. Growth is driven by rising contamination risks in food, water, and environmental sectors, along with advances in testing technologies. Pharmaceutical & biotech companies dominate the market due to stringent regulations for contamination control and product safety. The bacterial products segment holds the largest share, necessitating continual bacterial testin
TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating
21.04.2026 10:53
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 8 Best Large Cap Stocks to Invest In Right Now. On April 13, TD Cowen reduced its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) from $683 to $625 and kept its Buy rating on the stock. The research firm raised its Q1 EPS estimate from […]
Unlocking Q1 Potential of Thermo Fisher (TMO): Exploring Wall Street Estimates for Key Metrics
20.04.2026 13:15
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings
20.04.2026 11:01
Thermo Fisher Scientific Inc. is a high-quality, stable business, but stock is currently overvalued relative to growth outlook. Read more on TMO stock here.